Moderna announces new combination vaccine candidate targeting COVID-19 and flu

seekingalpha2021-09-09

(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu. Moderna highlighted the strength of its pipeline and revised ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Leekeez
2021-09-14
Leekeez
Ok
光辉岁月168
2021-09-10
光辉岁月168
Cash cow imagine 50% of the world population vaccinated
- KDaDa:
  Wow!
Lalalanana
2021-09-10
Lalalanana
Up up up
koolgal
2021-09-10
koolgal
Moderna is in the money with 2 in 1 Covid-19 vaccine cum flu. Investors can expect bumper profits along the way. 👍😉🚀🚀🚀
PhilipGoh
2021-09-10
PhilipGoh
Yes buy[开心]
FT585
2021-09-10
FT585
Nice

发表看法

224

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1169339361?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-09-09 22:21","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1169339361","market":"us","top_or_hot":-1,"title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","media":"seekingalpha","content":"<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","article_id":"1169339361","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","pubTimestamp":1631197303,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"莫德纳宣布针对新冠肺炎和流感的新组合候选疫苗","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":886318498,"gmtCreate":1631550514214,"gmtModify":1632807645773,"author":{"id":"4089085863454690","authorId":"4089085863454690","name":"Leekeez","avatar":"https://static.tigerbbs.com/0dc7b69aff39f86a9dc2217fe596c9af","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4089085863454690","authorIdStr":"4089085863454690"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/886318498","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":881097592,"gmtCreate":1631280469516,"gmtModify":1632883463717,"author":{"id":"3554819591940598","authorId":"3554819591940598","name":"光辉岁月168","avatar":"https://static.tigerbbs.com/d49448839db6ec13a56ec95df9761db9","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3554819591940598","authorIdStr":"3554819591940598"},"htmlText":"Cash cow imagine 50% of the world population vaccinated","listText":"Cash cow imagine 50% of the world population vaccinated","text":"Cash cow imagine 50% of the world population vaccinated","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/881097592","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5856221,"gmtCreate":1631549536096,"gmtModify":1634800331500,"authorId":3586642856771590,"author":{"id":3586642856771590,"idStr":"3586642856771590","authorId":3586642856771590,"name":"KDaDa","avatar":"https://static.tigerbbs.com/bbf594380f656556b95e862fd6513d46","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":881097592,"type":1,"supId":0,"prevId":0,"content":"Wow!","text":"Wow!","html":"Wow!"}],"langContent":"EN"},{"id":883491116,"gmtCreate":1631261670435,"gmtModify":1631890285461,"author":{"id":"3575357409343512","authorId":"3575357409343512","name":"Lalalanana","avatar":"https://static.tigerbbs.com/1dc07195419b4d0af32837fd05440883","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575357409343512","authorIdStr":"3575357409343512"},"htmlText":"Up up up&nbsp;","listText":"Up up up&nbsp;","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883491116","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883282507,"gmtCreate":1631244428309,"gmtModify":1631884310487,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"htmlText":"Moderna is in the money with 2 in 1 Covid-19 vaccine cum flu.&nbsp; Investors can expect bumper profits along the way. 👍😉🚀🚀🚀","listText":"Moderna is in the money with 2 in 1 Covid-19 vaccine cum flu.&nbsp; Investors can expect bumper profits along the way. 👍😉🚀🚀🚀","text":"Moderna is in the money with 2 in 1 Covid-19 vaccine cum flu. Investors can expect bumper profits along the way. 👍😉🚀🚀🚀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883282507","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":883641800,"gmtCreate":1631239769300,"gmtModify":1631890277449,"author":{"id":"3574730309796268","authorId":"3574730309796268","name":"PhilipGoh","avatar":"https://static.tigerbbs.com/d6085185a57dcb9a222e871338387428","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3574730309796268","authorIdStr":"3574730309796268"},"htmlText":"Yes buy[开心]&nbsp;","listText":"Yes buy[开心]&nbsp;","text":"Yes buy[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883641800","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":883650603,"gmtCreate":1631239155602,"gmtModify":1631890258060,"author":{"id":"3562726241279787","authorId":"3562726241279787","name":"FT585","avatar":"https://static.tigerbbs.com/734b50619b12425294cb4715814bdedb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3562726241279787","authorIdStr":"3562726241279787"},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/883650603","repostId":1169339361,"repostType":4,"repost":{"id":"1169339361","kind":"news","pubTimestamp":1631197303,"share":"https://www.laohu8.com/m/news/1169339361?lang=&edition=full","pubTime":"2021-09-09 22:21","market":"us","language":"en","title":"Moderna announces new combination vaccine candidate targeting COVID-19 and flu","url":"https://stock-news.laohu8.com/highlight/detail?id=1169339361","media":"seekingalpha","summary":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine c","content":"<p>(Sept 9)&nbsp;<a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> jumped over 5% in early trading,&nbsp;after&nbsp;it announces new combination vaccine candidate targeting COVID-19 and flu.</p>\n<p><img src=\"https://static.tigerbbs.com/7eb113e06f2c08fc7e2b8910f8df71f8\" tg-width=\"1154\" tg-height=\"564\" referrerpolicy=\"no-referrer\"></p>\n<p>Moderna&nbsp;highlighted the strength of its pipeline and revised the cash position ahead of its R&amp;D Day Scheduled for&nbsp;Thursday at 8.00 AM EST.</p>\n<p>Issuing an update on R&amp;D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.</p>\n<p>mRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.</p>\n<p>With 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.</p>\n<p>Updating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end&nbsp;of the previous quarter.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna announces new combination vaccine candidate targeting COVID-19 and flu</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna announces new combination vaccine candidate targeting COVID-19 and flu\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-09 22:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised ...</p>\n\n<a href=\"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://seekingalpha.com/news/3738257-moderna-updates-on-cash-position-and-unveils-new-combined-vaccine-candidate","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1169339361","content_text":"(Sept 9) Moderna, Inc. jumped over 5% in early trading, after it announces new combination vaccine candidate targeting COVID-19 and flu.\n\nModerna highlighted the strength of its pipeline and revised the cash position ahead of its R&D Day Scheduled for Thursday at 8.00 AM EST.\nIssuing an update on R&D programs, the company said it added a new combination vaccine candidate to the pipeline named mRNA-1073, which combines its COVID-19 vaccine and flu vaccine candidate.\nmRNA-1073, for which Moderna (MRNA) owns worldwide commercial rights, encodes for COVID-19 spike protein and the Flu HA glycoproteins.\nWith 22 clinical studies currently underway, the company now boasts 37 programs in development across 34 development candidates.\nUpdating the liquidity level, the company announced its cash position at about $15B as of August 31, up from ~$12.2B at the end of the previous quarter.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":224,"commentSize":39,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1169339361"}